Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
303 Leser
Artikel bewerten:
(1)

LeadsRx Attribution Gives Marketers Impartial Performance Marketing Data to Compare Podcast Ads Vs. Other Ad Channels

PORTLAND, OR / ACCESSWIRE / February 23, 2022 / The podcasting business is experiencing exponential growth with more than 130 million people expected to listen to them in 2022. Each month approximately 56 million people listen to podcasts served up by Spotify and Apple Podcast alone. It's why advertisers are tuning in and are willing to spend upwards of $800 million dollars to reach consumers - with little knowledge of how those ads perform when compared to advertising on other mediums.

"Understanding podcast advertising's interaction with other channels is critical for impartial insights and accurate measurement of return on ad spend," said AJ Brown, founder and CEO of LeadsRx. "Anyone advertising on podcasts or producing their own podcasts wants to be able to say they know how podcasts ads perform versus CTV, OTT, TV, radio, digital or other mediums - LeadsRx Attribution does that today."

In 2020, LeadsRx announced it was the first marketing analytics company to deliver the ability to measure real-time podcast ad performance in an unbiased way alongside other advertising on other mediums, digital ads, TV or radio broadcast commercials, and even direct mail. The capability means advertisers can finally evaluate their return on podcast advertising campaigns and make in-flight optimization changes helping to reduce wasted ad spend.

LeadsRx Attribution dashboard: Podcast attribution appears alongside other marketing touchpoints.

Credit for conversion is distributed according to a selected attribution model.

By looking holistically at all channels together marketers have the impartial view of the customer journey and insights into how well podcast ads are performing in a true multi-touch attribution environment.

The podcast platform's explosive growth has led to a number of recent acquisitions of podcast attribution and analytics point solutions, highlighting the need to validate the performance of podcasts for current and future advertisers. iHeartMedia's acquisition of Triton Digital, LeadsRx is happy to have worked with both companies, in 2020 and the recent acquisition of Podsights and Chartable by Spotify - as well as its purchase of Megaphone in 2020 - are two examples of the evolving podcasting landscape.

"Podcasting hosting services can tell advertisers where their audience is listening, from which device, and on what app, but it's not enough," said Brown. "Advertisers need to trust that they have unbiased listener data necessary to optimize their ad spend and ensure it measures up to the performance of their ads across any other channel.'

"LeadsRx Attribution gives advertisers the impartial marketing attribution solution required to measure performance of marketing across podcasts and other marketing channels," said Brown.

To learn more about the LeadsRx suite of offerings, from multi-touch attribution, to privacy-first customer journey analytics, to data clean rooms, to the concept of "People + Data = Better," visit LeadsRx.com.

About LeadsRx

Guided by an ethos of impartiality, consumer privacy, and quality first-party data, LeadsRx provides SaaS software and services that has helped marketers at more than 5,000 global and local brands and agencies increase customer acquisition efficiency, grow lifetime value, and identify wasted ad spend. The LeadsRx foundational technology is its unique Universal Pixel that has collected more than 2 billion personas for anonymous individuals - not personal identities, but the characteristics or demographic attributes that make up the type of customer or customers represented by their digital experience across devices, browsers, and apps. LeadsRx is an Unbounce company. To learn more about how LeadsRx can support you in marketing transformation visit LeadsRx.com. Connect with LeadsRx on Twitter, LinkedIn and Facebook.

For more information
Jeff Fishburn
Fishburn PR for LeadsRx
jeff@fishburnpr.com

SOURCE: LeadsRx



View source version on accesswire.com:
https://www.accesswire.com/689958/LeadsRx-Attribution-Gives-Marketers-Impartial-Performance-Marketing-Data-to-Compare-Podcast-Ads-Vs-Other-Ad-Channels

© 2022 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.